Learn More
Medchemexpress LLC Benzamide, 2-[[5-bromo-2-[[1-(methylsulfonyl)-4-piperidinyl)amino]-4-pyrimidinyl]amino]-6-fluoro- | 2488892-01-7 | C17H20BrFN6O3S | 25 MG

Supplier: Medchemexpress LLC 25MGHY151069
TMX-2039 is a pan-CDK inhibitor for both cell cycle CDKs (CDK1, CDK2, CDK4, CDK5, and CDK6) and transcriptional CDKs (CDK7 and CDK9). It acts as a ligand for target proteins for PROTACs, demonstrating IC50 values against CDK1 (2.6 nM), CDK2 (1.0 nM), CDK4 (52.1 nM), CDK5 (0.5 nM), CDK6 (35.0 nM), CDK7 (32.5 nM), and CDK9 (25 nM).
- Pan-CDK inhibitor
- Inhibits cell cycle CDKs
- Inhibits transcriptional CDKs
- Ligand for target protein for PROTACs
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.